Central nervous actions of beta-adrenoreceptor antagonists.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D001519:Behavior / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects* / Q000502:physiology*; D002493:Central Nervous System Diseases / Q000188:drug therapy; D000882:Haplorhini; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D011943:Receptors, Adrenergic, beta / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D011433:Propranolol